Literature DB >> 16425258

Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis.

Renu Wadhwa1, Syuichi Takano, Kamaljit Kaur, Custer C Deocaris, Olivia M Pereira-Smith, Roger R Reddel, Sunil C Kaul.   

Abstract

Mortalin, also known as mthsp70/GRP75/PBP74, interacts with the tumor suppressor protein p53 and inactivates its transcriptional activation and apoptotic functions. Here, we examined the level of mortalin expression in a large variety of tumor tissues, tumor-derived and in vitro immortalized human cells. It was elevated in many human tumors, and in all of the tumor-derived and in vitro immortalized cells. In human embryonic fibroblasts immortalized with an expression plasmid for hTERT, the telomerase catalytic subunit, with or without human papillomavirus E6 and E7 genes, we found that subclones with spontaneously increased mortalin expression levels became anchorage-independent and acquired the ability to form tumors in nude mice. Furthermore, overexpression of mortalin was sufficient to increase the malignancy of breast carcinoma cells. The study demonstrates that upregulation of mortalin contributes significantly to tumorigenesis, and thus is a good candidate target for cancer therapy. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16425258     DOI: 10.1002/ijc.21773

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  81 in total

1.  The DNLZ/HEP zinc-binding subdomain is critical for regulation of the mitochondrial chaperone HSPA9.

Authors:  Michael T Vu; Peng Zhai; Juhye Lee; Cecilia Guerra; Shirley Liu; Michael C Gustin; Jonathan J Silberg
Journal:  Protein Sci       Date:  2012-01-04       Impact factor: 6.725

Review 2.  On the brotherhood of the mitochondrial chaperones mortalin and heat shock protein 60.

Authors:  Custer C Deocaris; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2006       Impact factor: 3.667

3.  Mortalin is a prognostic factor of gastric cancer with normal p53 function.

Authors:  Koji Ando; Eiji Oki; Yan Zhao; Ayae Ikawa-Yoshida; Hiroyuki Kitao; Hiroshi Saeki; Yasue Kimura; Satoshi Ida; Masaru Morita; Tetsuya Kusumoto; Yoshihiko Maehara
Journal:  Gastric Cancer       Date:  2013-07-05       Impact factor: 7.370

4.  Circulating mortalin autoantibody--a new serological marker of liver cirrhosis.

Authors:  Wen-Jing Lu; Nishant Saxena; John M Luk; Sunil C Kaul; Renu Wadhwa
Journal:  Cell Stress Chaperones       Date:  2015-04-24       Impact factor: 3.667

5.  Secretion modification region-derived peptide disrupts HIV-1 Nef's interaction with mortalin and blocks virus and Nef exosome release.

Authors:  Martin N Shelton; Ming-Bo Huang; Syed A Ali; Michael D Powell; Vincent C Bond
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

6.  2- and N6-functionalized adenosine-5'-diphosphate analogs for the inhibition of mortalin.

Authors:  Mitchell A Moseng; Jay C Nix; Richard C Page
Journal:  FEBS Lett       Date:  2019-06-18       Impact factor: 4.124

Review 7.  Mitochondrial dysfunction in cancer: Potential roles of ATF5 and the mitochondrial UPR.

Authors:  Pan Deng; Cole M Haynes
Journal:  Semin Cancer Biol       Date:  2017-05-10       Impact factor: 15.707

8.  Understanding the functional interplay between mammalian mitochondrial Hsp70 chaperone machine components.

Authors:  Arvind Vittal Goswami; Balasubramanyam Chittoor; Patrick D'Silva
Journal:  J Biol Chem       Date:  2010-04-14       Impact factor: 5.157

9.  Molecular profiles of Quadriceps muscle in myostatin-null mice reveal PI3K and apoptotic pathways as myostatin targets.

Authors:  Ilham Chelh; Bruno Meunier; Brigitte Picard; Mark James Reecy; Catherine Chevalier; Jean-François Hocquette; Isabelle Cassar-Malek
Journal:  BMC Genomics       Date:  2009-04-27       Impact factor: 3.969

10.  Role of Magmas in protein transport and human mitochondria biogenesis.

Authors:  Devanjan Sinha; Neha Joshi; Balasubramanyam Chittoor; Priyanka Samji; Patrick D'Silva
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.